HomeNews

News

A Dedication to New Therapies for MPN Regardless of Scientific Challenges

A researcher mentioned the evolving understanding of myeloproliferative neoplasms (MPNs), from their preliminary classification to their potential for development, and emphasised the scientific...

GD2 CAR T Cells Present Promise In opposition to DMG

January 2, 2025, ...

Oncology Nurses Making a Distinction in Sufferers With Most cancers

Two oncology nurses nominated for the 2024 Extraordinary Healer Award spotlight the compassionate, patient-centered care that builds belief and improves the lives of...

A Affected person’s Self-Advocacy Results in an Important Thrombocythemia Prognosis in Her 30s

Regardless of preliminary dismissal of her issues, a affected person's persistent advocacy for her personal well being led to a analysis of important...

Asking Questions About Therapy Choices for MPN

A affected person with myeloproliferative neoplasm (MPN) advocates for proactive communication with healthcare suppliers to discover all therapy choices, together with new medication...

Hot Topics